Clinical Trial Update: Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients

View source ↗

Summary

Prospective observational study evaluating intralesional Pentostam for cutaneous leishmaniasis in Israeli patients; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Pentostam (sodium stibogluconate)

Snippet

Sponsor: Sheba Medical Center | Conditions: Cutaneous Leishmaniasis | Status: UNKNOWN